Vincristine PK and PD in the AYA Population Compared to Younger Children

Status unconfirmed

Conditions studied: Leukemia, Acute Lymphoblastic, Leukemia

In brief

The trial is to determine if a difference exists in the way that adolescents and young adults metabolize the chemotherapy agent vincristine compared to younger children.

Key facts

Study ID

NCT02360930

Run by

Children's Hospital Los Angeles

People needed

30

Starts

2014-09-01

Expected to finish

2015-07-01

Last updated by the study team

2015-06-22

Who can join

Age: 1 and older, up to 24. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients ages 1-24 years of age with Acute Lymphoblastic Leukemia
• Patient diagnosed with Acute Lymphoblastic Leukemia (ALL) in Induction phase of therapy
• Patient diagnosed with Acute Lymphoblastic Leukemia (ALL) in first remission in Maintenance phase of therapy Treatment plan for induction therapy includes vincristine given at weekly intervals.
• Treatment plan for Maintenance therapy includes vincristine given at monthly intervals.

You may not qualify if…

• Patients without a central line in induction phase of therapy

Where it is running

• Children's Hospital Los Angeles — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.